A synthetic peptide for use as a blocking control in assays to test for specificity of PLUNC antibody, Alternative Names: PLUNC control peptide, PLUNC antibody Blocking Peptide, Anti-PLUNC Blocking Peptide, Palate Lung And Nasal Epithelium Carcinoma Associated Blocking Peptide, LUNX Blocking Peptide, NASG Blocking Peptide, SPLUNC1 Blocking Peptide, SPURT Blocking Peptide, bA49G10.5 Blocking Peptide
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
BPIFA1
(BPI Fold Containing Family A, Member 1 (BPIFA1))
Synonyme
LUNX Peptide, NASG Peptide, PLUNC Peptide, SPLUNC1 Peptide, SPURT Peptide, bA49G10.5 Peptide, Plunc Peptide, BPI fold containing family A member 1 Peptide, BPI fold containing family A, member 1 Peptide, BPIFA1 Peptide, Bpifa1 Peptide
Hintergrund
PLUNC is the human homolog of murine plunc and is specifically expressed in the upper airways and nasopharyngeal regions. The exact biological function of this protein is not known, however, it has been suggested to be involved in inflammatory responses to irritants in the upper airways. It may also serve as a potential molecular marker for detection of micrometastasis in non-small-cell lung cancer.